Schedule 13G ownership disclosure
Protalix BioTherapeutics Inc
Security class unavailable · CUSIP: 74365A309
Event date: 2021-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-21-017958
- Form type
- SC 13G
- Filer
- Burrage Capital Management LLC
- CIK
- CIK 1796461
- Filed
- Jul 30, 2021
- Reporting period
- Jun 30, 2021
- Description
- Schedule 13G beneficial ownership